Entrepreneurs Investment Meet

Pharmaceutical companies are actively developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Key players operating in the global antibiotic market include Pfizer Inc., Astellas Pharma, Inc, Roche, Novartis AG, Bristol-Myers Squibb Co., Bayer HealthCare AG, Abbott Laboratories, MiddleBrook Pharmaceuticals, Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., and Kyorin Pharmaceutical Co., Ltd. Supportive government legislations, such as the Generating Antibiotics Incentives Now (GAIN) Act are expected to expedite the approval process. GAIN Act has provisions which facilitate development of therapy against antibiotic resistant pathogens.

 

    Related Conference of Entrepreneurs Investment Meet

    June 13-14, 2019 |

    10th European Immunology Conference

    Berlin, Germany
    July 29-30 2019

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands
    July 29-30, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    November 12-13, 2019

    13th International Congress on Autoimmunity

    Brisbane, Australia
    November 21-22, 2019

    World Conference on Vaccine and Immunology

    Dubai, UAE
    November 25-26 , 2019

    Global meet on Immunology and Molecular Biology

    Paris, France
    November 28-29, 2019

    International Conference on Vaccines and Immune Response

    Helsinki, Finland

    Entrepreneurs Investment Meet Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in